InnoCentive

/C O R R E C T I O N -- InnoCentive/

    Beijing and Moscow (ots/PRNewswire) - In the news release, InnoCentive Continues to Grow Its Virtual Scientific Network by Adding Leading Universities Throughout China and Russia, issued earlier today by InnoCentive over PR Newswire, we are advised by the client that the quote in the third graph should be attributed to "Mr. Ali Hussein" rather than "Mr. Hussein" as originally issued inadvertently.  Complete, corrected release follows:

    - Newly Signed Collaborative Agreements Further Enhance Innocentive's Innovative Virtual Scientific Network of Distributed R&D

    InnoCentive today announced that it has expanded its relationships with leading scientific universities across China and Russia by signing partnerships with the College of Chemistry at Huazhong Normal University, Xiamen University and Zhejiang University in China, Tomsk State University, Tula State University, Arkangelsk State University, and Far East State University in Russia.

    With today's agreements, InnoCentive now has partnerships with twenty-nine leading research-based universities located throughout Russia, and fourteen in China. These newest research-based universities add to the pool of global scientific minds available online to offer cost-effective, cutting-edge solutions for innovation-driven companies on InnoCentive's website. InnoCentive offers companies an opportunity to increase their R&D potential by posting challenges to a confidential online forum and gaining access to leading scientific minds.

    "These agreements underscore the mutual commitment between these institutions and InnoCentive to foster scientific innovation and advance science in the global market. China and Russia continue to be two of InnoCentive's top markets for scientific expertise, along with India and the U.S., and we look forward to establishing relationships with additional universities and bringing unique scientific opportunities to local scientists," said Mr. Ali Hussein. "This collaboration with the institutions reinforces our vision to move towards the forefront of scientific innovation. A scientist or researcher working on our platform does not have to emigrate to innovate." Hussein added, "InnoCentive's vision and efforts are global. We are using our network to realize global untapped capabilities. These agreements further enhance our efforts to successfully integrate highly qualified research minds across national and institutional boundaries."

    InnoCentive's virtual laboratory brings together leading global corporations and scientists from around the globe in order to solve tough R&D challenges. Companies including Boeing, Dow Chemical, Eli Lilly and Company, and Procter & Gamble, which collectively spend billions of dollars on R&D, post scientific problems confidentially on the InnoCentive website where more than 80,000 scientists and scientific organizations located in more than 175 countries can solve them. Scientists who deliver solutions that best meet InnoCentive's challenge requirements receive financial awards ranging up to USD$100,000.

    About InnoCentive

    InnoCentive is the first online forum that allows world-class scientists and science-based companies to collaborate in a global scientific community to achieve innovative solutions to complex challenges. InnoCentive is an e-business venture of Eli Lilly and Company, a leading innovation-driven pharmaceutical company. To learn more, visit the InnoCentive website at www.innocentive.com.

    NOTE: InnoCentive and InnoCentive Challenge are registered trademarks of InnoCentive, Inc. Other product or service names mentioned herein are the trademarks of their respective owners.

      For More Information:
      Tara Bal
      Media Contact for InnoCentive
      +1-510-226-6780, ext. 162
      innocentive-pr@e21corp.com

    Web site: http://www.innocentive.com

ots Originaltext: InnoCentive
Im Internet recherchierbar: http://www.presseportal.ch

Contact:
Tara Bal of e21, +1-510-226-6780, ext. 162, or
innocentive-pr@e21corp.com, for InnoCentive



Weitere Meldungen: InnoCentive

Das könnte Sie auch interessieren: